RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Sangui BioTech International - Stock

Sangui BioTech International Stocks 2024

Sangui BioTech International Stocks

208.6 M

Ticker

SGBI

ISIN

US80105B1017

WKN

906757

In 2024, Sangui BioTech International had 208.6 M outstanding stocks, a 2.16% change from the 204.19 M stocks in the previous year.

The Sangui BioTech International Stocks history

YEARNUMBER OF STOCKS (undefined USD)
2022208.6
2021204.19
2020201.75
2019197.13
2018188.2
2017178.46
2016154.81
2015145.64
2014137.03
2013128.55
2012116.69
201193.92
201075.89
200959.28
200850
200750

Sangui BioTech International shares outstanding

  • 3 years

  • 5 years

  • 10 years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Sangui BioTech International earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Sangui BioTech International's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Sangui BioTech International’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Sangui BioTech International's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Sangui BioTech International Aktienanalyse

What does Sangui BioTech International do?

Sangui Biotech International Inc. is a biotechnology company based in the USA that focuses on the research and development of medical products. It was founded in 1994 by Dr. Joachim Fleing with the vision of developing a new type of blood substitute that could replace blood transfusions. The company's business model is centered around developing and marketing products that help combat blood diseases and make blood supply safer. They have different divisions focusing on various aspects of medical research and development, including the development of blood substitute products, wound and scar healing products, and products for individuals with stomas. The company also has a line of products for blood clotting. They strive to be a leader in the medical industry and have already achieved success with their innovative products, receiving patents and awards. They collaborate with other companies and research institutions worldwide to develop new products and exchange research findings. Overall, Sangui Biotech International Inc. is an innovative and emerging biotechnology company dedicated to developing medical products to improve people's health and save lives. Sangui BioTech International ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Sangui BioTech International's Shares Outstanding

Sangui BioTech International's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Sangui BioTech International’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Sangui BioTech International’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Sangui BioTech International’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Sangui BioTech International Stock

How many stocks are there of Sangui BioTech International?

The current number of stocks of Sangui BioTech International is 208.6 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Sangui BioTech International are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Sangui BioTech International evolved in recent years?

The number of shares of Sangui BioTech International has increased by 2.16% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Sangui BioTech International as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Sangui BioTech International?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Sangui BioTech International pay?

Over the past 12 months, Sangui BioTech International paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Sangui BioTech International is expected to pay a dividend of 0 USD.

What is the dividend yield of Sangui BioTech International?

The current dividend yield of Sangui BioTech International is .

When does Sangui BioTech International pay dividends?

Sangui BioTech International pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Sangui BioTech International?

Sangui BioTech International paid dividends every year for the past 0 years.

What is the dividend of Sangui BioTech International?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Sangui BioTech International located?

Sangui BioTech International is assigned to the 'Health' sector.

Wann musste ich die Aktien von Sangui BioTech International kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Sangui BioTech International from 6/26/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/26/2024.

When did Sangui BioTech International pay the last dividend?

The last dividend was paid out on 6/26/2024.

What was the dividend of Sangui BioTech International in the year 2023?

In the year 2023, Sangui BioTech International distributed 0 USD as dividends.

In which currency does Sangui BioTech International pay out the dividend?

The dividends of Sangui BioTech International are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Sangui BioTech International

Our stock analysis for Sangui BioTech International Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sangui BioTech International Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.